This inventor holds 3 USPTO granted patents. Top assignee: Repligen Corporation. Active years: 1991-1993.
Company Filing History:
Years Active: 1991-1993
Title: Scott D. Putney: Innovator in Recombinant Proteins
Introduction
Scott D. Putney is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins for medical applications. With a total of 3 patents, his work has been instrumental in advancing therapeutic options for diseases such as AIDS.
Latest Patents
Among his latest patents, Scott D. Putney has developed novel recombinant HTLV-III fusion proteins. These proteins, denoted as R10, PB1, 590, and KH1, are designed for use in the diagnosis, prophylaxis, or therapy of AIDS. Specifically, protein R10 is a 95 kD fusion protein, protein PB1 is a 26 kD fusion protein, protein 590 is an 86 kD fusion protein, and protein KH1 is a 70 kD fusion protein. These innovations are particularly valuable for preparing vaccines against the HTLV-III virus.
Career Highlights
Scott D. Putney is currently associated with Repligen Corporation, where he continues to push the boundaries of biotechnology. His work has not only contributed to scientific knowledge but has also paved the way for practical applications in healthcare.
Collaborations
Throughout his career, Scott has collaborated with talented individuals such as Debra Lynn and Kashayar Javaherian. These partnerships have enhanced the scope and impact of his research.
Conclusion
Scott D. Putney's innovative work in recombinant proteins exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for new therapeutic solutions and improving patient outcomes.